Clinical Trials Logo

Recurrent NSCLC clinical trials

View clinical trials related to Recurrent NSCLC.

Filter by:
  • None
  • Page 1

NCT ID: NCT00813332 Recruiting - Advanced NSCLC Clinical Trials

Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)

Start date: October 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the efficacy and safety of Endostar (Recombinant Human Endostatin) combined with Docetaxel and single Docetaxel through multi-center, double-blinding, randomized controlled, phase Ⅳ clinical trial for NSCLC cases who have obvious progressive disease or intolerant adverse effects in first-line chemotherapy.